eMedicine Specialties > Dermatology > Pediatric Diseases

Dermatofibrosis Lenticularis (Buschke-Ollendorf Syndrome)

Author: Lukasz Matusiak, MD, Assistant, Department and Clinic of Dermatology, Venereology and Allergology, Medical University of Wroclaw
Coauthor(s): Grazyna Szybejko-Machaj, MD, PhD, Assistant Professor, Department of Dermatology, Wroclaw Medical University; Jacek C Szepietowski, MD, PhD, Professor, Vice-Head, Department of Dermatology, Venereology and Allergology, Wroclaw Medical University; Director of the Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Poland
Contributor Information and Disclosures

Updated: Jul 2, 2008

Introduction

Background

Buschke-Ollendorff syndrome is a rare hereditary disorder of connective tissue. It is inherited as a pleiotropic autosomal dominant trait with incomplete penetrance. This condition was described for the first in 1902 and was termed "scleroderma adultorum" by Abraham Buschke. Then, Heinrich Ernst Albers-Schönberg described this syndrome in 1915. Finally, Buschke and Helene Ollendorff Curth described it in 1928 in a 41-year-old woman. Buschke-Ollendorff syndrome is considered to be a hamartoma, an association of osteopoikilosis and connective tissue nevi.1,2,3,4,5

Pathophysiology

In the presence of 10% calf serum, cultured fibroblasts of patients with Buschke-Ollendorff syndrome produce 2-8 times more tropoelastin than fibroblasts of healthy individuals. Elastin production is higher in involved and uninvolved skin.6,7,8 Elevated elastin mRNA levels suggest that Buschke-Ollendorff syndrome may result from abnormal regulation of extracellular matrix, leading to increased levels of elastin mRNA and increased accumulation of elastin in the dermis [10]. Noteworthy is that heterozygous loss-of-function mutation in the LEMD3 (LEM domain containing 3) gene (locus 12q14) for an inner nuclear membrane protein has been identified in patients with osteopoikilosis with or without Buschke-Ollendorff syndrome.5,9,10,11

Frequency

International

Buschke-Ollendorff syndrome is rare (1 case per 20,000 population).5

Mortality/Morbidity

The cause of mortality may be malignant transformation of bone densities into osteosarcoma, chondrosarcoma, and giant cell tumor. The otosclerosis with hearing impairment, stenosis of the aortae, and diabetes frequently found in this syndrome make the patient's condition serious.4,12,13

Race

No racial predilection is reported for Buschke-Ollendorff syndrome.5

Sex

The incidence is equal for males and females.5

Age

Skin lesions are visible in neonates just after birth. Other factors of the syndrome are revealed with time.4

Clinical

History

History findings are as follows1,4,5,14,15 :

  • The coexistence of cutaneous lesions, such as disseminated lenticular dermatofibrosis, and skeletal changes, such as osteopoikilosis, characterize Buschke-Ollendorff syndrome.
  • Cutaneous lesions appear in childhood, often in the first year of life. They may be observed in the fetus. Rarely, they may occur in adulthood.
  • They are usually located on the trunk and the proximal extremities, and the skin folds are often involved.
  • The lesions are painless, nonpruritic, and enlarge with the growth of the child.

Physical

Physical findings are as follows1,3,4,5,14,15,16,17,18,19,20,21 :

  • Buschke-Ollendorff syndrome is an association of disseminated lenticular dermatofibrosis and osteopoikilosis. The dermal lesions are composed of collagen and elastin fibers and, in some instances, mucopolysaccharides. The cutaneous lesions are usually localized on the trunk; in the sacrolumbar region; and, symmetrically, on the extremities. Occasionally, the lesions may be found on the head. They present with slightly elevated and flattened yellowish papules and nodules grouped together forming plaques several centimeters in diameter. The plaques are of irregular shape and sharply demarcated. They are numerous, painless, nonpruritic, and develop over several years. In some individuals, only dermal or osteopoikilosis manifestations may be present.
  • Other findings in Buschke-Ollendorff syndrome include nasolacrimal duct obstruction, amblyopia, strabismus, benign lymphoid hyperplasia, hypopigmentation, and short stature.
  • The bones demonstrate osteopoikilosis in the stratum spongiosum of the epiphysis and the metaphysis of the long bones, especially in the fingers, the ulna, and the radius. Focal bone densities are often present in the carpal bones, the metacarpal bones, and the phalanges. They also occur in the lumbosacral spine. Each focal area of density may measure from 1-16 mm in length. Other forms of osteosclerosis, including osteopathia striata, melorheostosis, and mixed sclerosis bone dystrophy, may be present.
  • Congenital spinal stenosis, disc herniation, clubfoot deformity, and nerve root compression may be present.
  • Otosclerosis with or without hearing loss may occur. It is caused by bone resorption and redeposition, and it may be clinically asymptomatic; however, otosclerosis is a rare phenomenon in patients with Buschke-Ollendorff syndrome.

Causes

The syndrome is inherited as an autosomal dominant variant with incomplete penetrance.1,4,5

More on Dermatofibrosis Lenticularis (Buschke-Ollendorf Syndrome)

Overview: Dermatofibrosis Lenticularis (Buschke-Ollendorf Syndrome)
Differential Diagnoses & Workup: Dermatofibrosis Lenticularis (Buschke-Ollendorf Syndrome)
Treatment & Medication: Dermatofibrosis Lenticularis (Buschke-Ollendorf Syndrome)
Follow-up: Dermatofibrosis Lenticularis (Buschke-Ollendorf Syndrome)
Multimedia: Dermatofibrosis Lenticularis (Buschke-Ollendorf Syndrome)
References
[ CLOSE WINDOW ]

References

  1. Benli IT, Akalin S, Boysan E, Mumcu EF, Kis M, Türkoglu D. Epidemiological, clinical and radiological aspects of osteopoikilosis. J Bone Joint Surg Br. Jul 1992;74(4):504-6. [Medline].

  2. Crivellato E. Disseminated nevus anelasticus. Int J Dermatol. Apr 1986;25(3):171-3. [Medline].

  3. Dahan S, Bonafe JL, Laroche M, et al. [Iconography of Buschke Ollendorff syndrome: x ray computed tomography and nuclear magnetic resonance of osteopoikilosis]. Ann Dermatol Venereol. 1989;116(3):225-30. [Medline].

  4. Lin F, Morrison JM, Wu W, Worman HJ. MAN1, an integral protein of the inner nuclear membrane, binds Smad2 and Smad3 and antagonizes transforming growth factor-beta signaling. Hum Mol Genet. Feb 1 2005;14(3):437-45. [Medline].

  5. de la Salmonière P, Janier M, Chemlal K, Lazareth I, Carlotti A, Charasson I, et al. [Buschke-Ollendorff syndrome]. Ann Dermatol Venereol. 1994;121(10):718-20. [Medline].

  6. Ehrig T, Cockerell CJ. Buschke-Ollendorff syndrome: report of a case and interpretation of the clinical phenotype as a type 2 segmental manifestation of an autosomal dominant skin disease. J Am Acad Dermatol. Dec 2003;49(6):1163-6. [Medline].

  7. Hellemans J, Preobrazhenska O, Willaert A, Debeer P, Verdonk PC, Costa T, et al. Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis. Nat Genet. Nov 2004;36(11):1213-8. [Medline].

  8. Trattner A, David M, Rothem A, Ben-David E, Sandbank M. Buschke-Ollendorff syndrome of the scalp: histologic and ultrastructural findings. J Am Acad Dermatol. May 1991;24(5 Pt 2):822-4. [Medline].

  9. Ben-Asher E, Zelzer E, Lancet D. LEMD3: the gene responsible for bone density disorders (osteopoikilosis). Isr Med Assoc J. Apr 2005;7(4):273-4. [Medline].

  10. Grimer RJ, Davies AM, Starkie CM, Sneath RS. [Chondrosarcoma in a patient with osteopoikilosis. Apropos of a case]. Rev Chir Orthop Reparatrice Appar Mot. 1989;75(3):188-90. [Medline].

  11. Lagier R, Mbakop A, Bigler A. Osteopoikilosis: a radiological and pathological study. Skeletal Radiol. 1984;11(3):161-8. [Medline].

  12. Ayling RM, Evans PE. Giant cell tumor in a patient with osteopoikilosis. Acta Orthop Scand. Feb 1988;59(1):74-6. [Medline].

  13. Giro MG, Duvic M, Smith LT, Kennedy R, Rapini R, Arnett FC, et al. Buschke-Ollendorff syndrome associated with elevated elastin production by affected skin fibroblasts in culture. J Invest Dermatol. Aug 1992;99(2):129-37. [Medline].

  14. Morrison JG, Jones EW, MacDonald DM. Juvenile elastoma and osteopoikilosis (the Buschke--Ollendorff syndrome). Br J Dermatol. Oct 1977;97(4):417-22. [Medline].

  15. Schorr WF, Optiz JM, Reyes CN. The connective tissue nevus-osteopoikilosis syndrome. Arch Dermatol. Aug 1972;106(2):208-14. [Medline].

  16. Al Attia HM, Sherif AM. Buschke-Ollendorff syndrome in a grande multipara: a case report and short review of the literature. Clin Rheumatol. 1998;17(2):172-5. [Medline].

  17. Atherton DJ, Wells RS. Juvenile elastoma and osteopoikilosis (the Buschke-Ollendorf syndrome). Clin Exp Dermatol. Jan 1982;7(1):109-13. [Medline].

  18. Cantatore FP, Carrozzo M, Loperfido MC. Mixed sclerosing bone dystrophy with features resembling osteopoikilosis and osteopathia striata. Clin Rheumatol. Jun 1991;10(2):191-5. [Medline].

  19. Miklaszewska M, Szybejko-Machaj G, Szepietowski J. [Buschke-Ollendorf syndrome - case report with a literature review.]. Dermatol Klin Zabieg. 1999;2:85-9.

  20. Schnur RE, Grace K, Herzberg A. Buschke-Ollendorff syndrome, otosclerosis, and congenital spinal stenosis. Pediatr Dermatol. Mar 1994;11(1):31-4. [Medline].

  21. Woodrow SL, Pope FM, Handfield-Jones SE. The Buschke-Ollendorff syndrome presenting as familial elastic tissue naevi. Br J Dermatol. Apr 2001;144(4):890-3. [Medline].

  22. Smith AD, Waisman M. Connective tissue nevi; familial occurrence and association with osteopoikilosis. Arch Dermatol. Feb 1960;81:249-52. [Medline].

  23. Holbrook KA, Byers PH. Structural abnormalities in the dermal collagen and elastic matrix from the skin of patients with inherited connective tissue disorders. J Invest Dermatol. Jul 1982;79 Suppl 1:7s-16s. [Medline].

  24. Hassikou H, Tabache F, Safi S, Baaj M, Hadri L. Buschke-Ollendorff syndrome. Joint Bone Spine. Mar 2008;75(2):212-4. [Medline].

  25. Uitto J, Santa Cruz DJ, Starcher BC, Whyte MP, Murphy WA. Biochemical and ultrastructural demonstration of elastin accumulation in the skin lesions of the Buschke-Ollendorff syndrome. J Invest Dermatol. Apr 1981;76(4):284-7. [Medline].

[ CLOSE WINDOW ]

Further Reading

[ CLOSE WINDOW ]

Keywords

disseminated lenticular dermatofibrosis, osteopoikilosis, dermatofibrosis lenticularis disseminata with osteopoikilosis, ectodermal dysplasia of connective tissue, osteodermatopoikilosis, osteopathia condensans disseminata

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

Lukasz Matusiak, MD, Assistant, Department and Clinic of Dermatology, Venereology and Allergology, Medical University of Wroclaw
Disclosure: Nothing to disclose.

Coauthor(s)

Grazyna Szybejko-Machaj, MD, PhD, Assistant Professor, Department of Dermatology, Wroclaw Medical University
Disclosure: Nothing to disclose.

Jacek C Szepietowski, MD, PhD, Professor, Vice-Head, Department of Dermatology, Venereology and Allergology, Wroclaw Medical University; Director of the Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Poland
Disclosure: Stiefel Salary Employment

Medical Editor

Mark A Crowe, MD, Assistant Clinical Instructor, Department of Medicine, Division of Dermatology, University of Washington School of Medicine
Mark A Crowe, MD is a member of the following medical societies: American Academy of Dermatology and North American Clinical Dermatologic Society
Disclosure: Nothing to disclose.

Pharmacy Editor

David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Scott and White Clinic; Director Dermatology Residency Training Program, Scott and White Clinic
David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa
Disclosure: 3M Pharmaceutical Grant/research funds Other; Graceway Pharmaceuticals Grant/research funds Other

Managing Editor

Robert A Schwartz, MD, MPH, Professor and Head of Dermatology, Professor of Medicine, Professor of Pediatrics, Professor of Pathology, Professor of Preventive Medicine and Community Health, UMDNJ-New Jersey Medical School
Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and Sigma Xi
Disclosure: Nothing to disclose.

CME Editor

Glen H Crawford, MD, Assistant Clinical Professor, Department of Dermatology, University of Pennsylvania School of Medicine; Chief, Division of Dermatology, The Pennsylvania Hospital
Glen H Crawford, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, Phi Beta Kappa, and Society of USAF Flight Surgeons
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.